Cotinga Pharmaceuticals organizacji Cena/wartość księgowa
Jaka jest wartość Cena/wartość księgowa organizacji Cotinga Pharmaceuticals?
Wartość Cena/wartość księgowa organizacji Cotinga Pharmaceuticals, Inc. to -116.24
Jaka jest definicja Cena/wartość księgowa?
Wskaźnik ceny do sprzedaży(Price to book ratio) reprezentuje stosunek wartości akcji spółki do wartości księgowej na akcję.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Cena/wartość księgowa firm w Health Care sektor na TSXV w porównaniu do Cotinga Pharmaceuticals
Czym się zajmuję organizacja Cotinga Pharmaceuticals?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Firmy z cena/wartość księgowa podobne do Cotinga Pharmaceuticals
- Wartość Cena/wartość księgowa organizacji Black Iron to -120.34
- Wartość Cena/wartość księgowa organizacji HCA Healthcare to -120.12
- Wartość Cena/wartość księgowa organizacji Huntsman Exploration Inc to -118.25
- Wartość Cena/wartość księgowa organizacji Regeneus Ltd to -117.67
- Wartość Cena/wartość księgowa organizacji Changsheng International to -117.65
- Wartość Cena/wartość księgowa organizacji Sable Resources to -117.24
- Wartość Cena/wartość księgowa organizacji Cotinga Pharmaceuticals to -116.24
- Wartość Cena/wartość księgowa organizacji Astra to -113.97
- Wartość Cena/wartość księgowa organizacji A2Z Technologies Canada to -112.65
- Wartość Cena/wartość księgowa organizacji Taiga Motors to -112.18
- Wartość Cena/wartość księgowa organizacji Clean Power Hydrogen Plc to -108.51
- Wartość Cena/wartość księgowa organizacji Fabled Copper to -105.66
- Wartość Cena/wartość księgowa organizacji Astra Exploration Inc to -102.83